NCT06964789Not yet recruiting
The Mechatronic Remote Physiotherapy System (MRPS) in Remote Stroke Rehabilitation
The Mechatronic Remote Physiotherapy System (MRPS) in Remote Stroke Rehabilitation: A Pilot Controlled Trial for 'Early Supported Discharge'
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
The aim of this pilot trial is to examine and compare the safety and feasibility of enhanced Early Supported Discharge (ESD) through the Mechatronic Remote Physiotherapy System (MRPS) and traditional ESD after stroke. The main questions this trial aims to answer are: * Is enhanced ESD via the MRPS safe, feasible and significantly different compared to traditional ESD when administered to patients after stroke? * Do patients interact with and are they satisfied with the MRPS? * Is enhanced ESD cost-effective compared to traditional ESD? * Are there any adverse effects of the MRPS and what are the areas for further improvement? Participants in the experimental group will receive enhanced ESD through the MRPS. The intervention will be given for approximately 6-8 weeks in total. Frequency will be determined by how often the participants' use the MRPS themselves. Frequency of use and level of completion of each session will be monitored. Enhanced ESD therapy sessions will be designed to reflect traditional ESD sessions. Participants in the control group will receive traditional ESD. The intervention will be given for approximately 6-8 weeks in total with a frequency of 1-3 therapy visits per week (as per traditional ESD). Therapy sessions will be designed by therapists delivering the ESD service.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 14 (estimated)
- First submitted
- 23 Oct 2024
- Start date
- 1 Nov 2027
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- Institute of Technology, Sligo
- Diseases
- Stroke
- NCT number
- NCT06964789
What you commit to
- Study type: Interventional
- Planned participants: 14
- From 1 Nov 2027 to the primary completion date, 1 Mar 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have uncontrolled medical condition or another serious medication condition in addition to stroke;
Other
- Involvement in other studies or rehabilitation programmes;
- A level of disability that would prevent them from participating safely (as determined by ESD team);
- Low level technological literacy or resources (e.g. Wi-Fi) which would prevent access to MRPS platform;
- Unable to understand or follow directions.
Who the study is looking for
- A clinical diagnosis of stroke;
- Completed inpatient rehabilitation;
- A level of ability that would allow them to participate safely (as determined by ESD team);
- Cognitive ability to consent and take part;
- Technological ability and resources to allow them to access MRPS platform;
- A proficiency in the English Language.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.